Palo Alto Medical Foundation Health Care — Palo Alto, California

Public research footprint of Palo Alto Medical Foundation Health Care, compiled from the ClinicalTrials.gov public registry.

170

Registered studies

101

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT07391774 — Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed… (Recruiting)
NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)
NCT02311933 — Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Palo Alto Medical Foundation Health Care?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.